Your browser doesn't support javascript.
loading
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial.
Manji, Arif; Samson, Yvan; Deyell, Rebecca J; Johnston, Donna L; Lewis, Victor A; Zorzi, Alexandra P; Berman, Jason N; Brodeur-Robb, Kathy; Morrison, Ellen; Kee, Lynn; Kumar, Sushil; Baruchel, Sylvain; Whitlock, James A; Morgenstern, Daniel A.
Afiliação
  • Manji A; The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
  • Samson Y; CHU Sainte-Justine, Montréal, QC H3T 1C5, Canada.
  • Deyell RJ; BC Children's Hospital, Vancouver, BC V6H 3N1, Canada.
  • Johnston DL; Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
  • Lewis VA; Alberta Children's Hospital, Calgary, AB T3B 6A8, Canada.
  • Zorzi AP; Children's Hospital, London Health Sciences Centre, London, ON N6A 5W9, Canada.
  • Berman JN; Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
  • Brodeur-Robb K; C17 Council for Children's Cancer and Blood Disorders, Edmonton, AB T6G 2E1, Canada.
  • Morrison E; C17 Council for Children's Cancer and Blood Disorders, Edmonton, AB T6G 2E1, Canada.
  • Kee L; The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
  • Kumar S; Drug Metabolism & Pharmacokinetics, QPS Holdings LLC, Newark, DE 19711, USA.
  • Baruchel S; The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
  • Whitlock JA; The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
  • Morgenstern DA; The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
Cancers (Basel) ; 14(12)2022 Jun 17.
Article em En | MEDLINE | ID: mdl-35740650

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá